OKUR

OnKure Therapeutics

2.88 USD
--0.09
3.03%
At close Updated Oct 16, 4:00 PM EDT
Pre-market
After hours
2.85
--0.03
1.04%
1 day
-3.03%
5 days
-8.57%
1 month
21.52%
3 months
15.66%
6 months
-1.71%
Year to date
-66.2%
1 year
-84.51%
5 years
-97.93%
10 years
-97.93%
 

About: OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Employees: 46

0
Funds holding %
of 7,495 funds
0
Analysts bullish %
of 1 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™